France Vaccine Market Size, Share, and COVID-19 Impact Analysis, By Type (Subunit and mRNA), By Route of Administration (Oral, Parenteral, and Nasal), and France Vaccine Market Insights, Industry Trend, Forecasts to 2035

France Vaccine Market Insights Forecasts to 2035 

• The France Vaccine Market Size was Estimated at USD 2,788.7 Million in 2024
• The Market Size is Expected to Grow at a CAGR of around 4.97% from 2025 to 2035
• The France Vaccine Market Size is Expected to Reach USD 4,756.3 Million by 2035

According to a research report published by Spherical Insights & Consulting, the France Vaccine Market Size is anticipated to reach USD 4,756.3 million by 2035, Growing at a CAGR of 4.97% from 2025 to 2035. The increased focus on the safety and effectiveness of vaccines is boosting the growth of the market.

Market Overview 

The vaccine market is experiencing strong growth, underpinned by growing awareness of preventive healthcare and advances in vaccine technology. The latest developments include the speedy rollout of mRNA vaccines, especially under the spotlight during the COVID-19 pandemic, which have established a precedent for future vaccine development in other infectious diseases. Biological materials known as vaccines are designed to protect against infectious diseases. Usually, weakened or killed pathogens (like viruses or bacteria) or parts of these pathogens (like proteins or sugars) make up vaccines. By triggering the immune system to identify and remember the pathogen, vaccines enable the body to develop a faster and more robust defense if the disease is ever discovered again. This procedure keeps illness and lessens the spread of contagious diseases across populations.  A vital part of public health initiatives, vaccines can be administered by injection, oral tablet, or nasal spray, among other forms of administration. 

Report Coverage

This research report categorizes the market for the France vaccine market based on various segments and regions and forecasts revenue growth and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the France vaccine market. Recent market developments and competitive strategies such as expansion, product launch, development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the France vaccine market. 

Driving Factors

The market is fueled by the imposition of strict regulations aimed at encouraging vaccination among people. Furthermore, increased focus on the safety and effectiveness of vaccines is boosting the growth of the market. In addition, companies adopt stringent testing and quality assurance practices to ensure that products are of the highest safety standards, leading to increasing investments in research and development (R&D) to develop products that efficiently prevent disease and have few harmful side effects, thereby emerging as another significant growth driver. 

Restraining Factors

The vaccine market is confronted by various major challenges, such as supply-demand discrepancies and market concentration. Also, certain nations lack effective planning, forecasting, and procurement activities for vaccines. Vaccine access in lower-income nations is usually behind that of wealthier countries, with inequities in rates of vaccination.

Market Segmentation

The France vaccine market share is classified into type and route of administration.

• The mRNA segment held the highest share in 2024 and is expected to grow at a significant CAGR during the forecast period.

The France vaccine market is segmented by type into subunit and mRNA. Among these, the mRNA segment held the highest share in 2024 and is expected to grow at a significant CAGR during the forecast period. These vaccines present several benefits over conventional vaccines, including the ease of rapidly shifting antigen design and incorporating sequences from several variants in order to respond to new mutations in the virus genome. The versatility of these vaccines has been at the core of their market leadership. Success with mRNA-based COVID-19 vaccines has also triggered the creation of mRNA platforms for the prevention of other infectious diseases like the flu and RSV.

• The parenteral segment held the largest share in 2024 and is expected to grow at a significant CAGR during the forecast period.

The France vaccine market is segmented by route of administration into oral, parenteral, and nasal. Among these, the parenteral segment held the largest share in 2024 and is expected to grow at a significant CAGR during the forecast period. Parenteral administration, that is, injections into the body, is favored due to its quicker absorption, greater efficacy, and lower risk of contamination and degradation. Most vaccines available in the market are given intramuscularly or subcutaneously, which accounts for the dominance of this segment.

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the France vaccine market, along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market. 

List of Key Companies

• Seqirus
• GSK Plc
• Pfizer Inc.
• Sanofi
• Moderna Inc.
• AstraZeneca
• Merck & Co., Inc.
• Sinovac
• Others

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting and Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Market Segment

This study forecasts revenue at the global, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the France Vaccine Market based on the below-mentioned segments:

France Vaccine Market, By Type      

• Subunit
• mRNA

France Vaccine Market, By Route of Administration  

• Oral
• Parenteral
• Nasal